Company
Mission Therapeutics
Mission is the world leader in deubiquitylating enzyme (‘DUB’) drug discovery and development.
Also known as Mission Therapeutics Limited
- Business model
- B2B
- Headquarters
- Cambridge, United Kingdom
- Founded
- 2011
- Customers
- other pharmaceutical companies
- missiontherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Funding snapshot
- Latest round
- Undisclosed2025-10-15
Funding rounds
- Round, 2025
- 2025-10-15
- Grant
- 2024-07-02
- Round, 2024
- 2024-03-14
Loading relationship preview